New Report: Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

June 4, 2011 - PRLog -- Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, "Mucopolysaccharidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Mucopolysaccharidosis Therapeutics market. The report identifies the key trends shaping and driving the global Mucopolysaccharidosis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Mucopolysaccharidosis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

------------------------------------------------------------
Full Report Details at
- http://www.fastmr.com/prod/159597_mucopolysaccharidosis_t...
------------------------------------------------------------

Scope

* The report provides information on the key drivers and challenges of the Mucopolysaccharidosis Therapeutics market. Its scope includes:
* Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Mucopolysaccharidosis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
* Analysis of the current and future competition in the seven key countries Mucopolysaccharidosis Therapeutics market.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Mucopolysaccharidosis Therapeutics therapeutics market.
* Analysis of key recent licensing and partnership agreements in Mucopolysaccharidosis Therapeutics market


Reasons to buy

The report will enhance your decision making capability. It will allow you to -

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Mucopolysaccharidosis Therapeutics market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Mucopolysaccharidosis Therapeutics market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Mucopolysaccharidosis Therapeutics market landscape? - Identify, understand and capitalize.


Partial Table of Contents:

1 Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Mucpolysaccharidosis Therapeutics: Introduction
2.1 Overview
2.2 Epidemiology
2.3 Symptoms
2.4 Diagnosis
2.5 Treatment and Management Pattern
2.6 GlobalData Pipeline Report Guidance
3 Mucopolysaccharidosis Therapeutics: Market Characterization
3.1 MPS Therapeutics Market Size (2005-2010) - Global
3.2 MPS Therapeutics Market Forecast (2010-2017) - Global
3.3 MPS Therapeutics Market Size (2005-2010): The US
3.4 MPS Therapeutics Market Forecast (2010-2017): The US
3.5 MPS Therapeutics Market (2005-2010): France
3.6 MPS Therapeutics Market Forecast (2010-2017): France
3.7 MPS Therapeutics Market (2005-2010): Germany
3.8 MPS Therapeutics Market Forecast (2010-2017): Germany
3.9 MPS Therapeutics Market (2005-2010): Italy
3.10 MPS Therapeutics Market Forecast (2010-2017): Italy
3.11 MPS Therapeutics Market (2005-2010): Spain
3.12 MPS Therapeutics Market Forecast (2010-2017): Spain
3.13 MPS Therapeutics Market (2005-2010): The UK
3.14 MPS Therapeutics Market Forecast (2010-2017): The UK
3.15 MPS Therapeutics Market (2005-2010): Japan
3.16 MPS Therapeutics Market Forecast (2010-2017): Japan
3.17 Drivers and Barriers for the MPS Therapeutics Market
3.17.1 Drivers for the Mucopolysaccharidosis Therapeutics Market
3.17.2 Barriers for the Mucopolysaccharidosis Therapeutics Market
3.18 Opportunity and Unmet Need Analysis
3.19 Key Takeaway
4 Mucopolysaccharidosis Therapeutics: Competitive Assessment
4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Product Profile for the Major Marketed Products in the Mucopolysaccharidosis Therapeutics Market
4.2.1 Aldurazyme (laronidase)
4.2.2 Elaprase (idursulfase)
4.2.3 Naglazyme (galsulfase)
4.3 Key Takeaway
5 Mucopolysaccharidosis Therapeutics: Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Mucopolysaccharidosis Therapeutics Pipeline - Pipeline by Phases of Development
5.3.1 Mucopolysaccharidosis Therapeutics - Phase III Pipeline
5.3.2 Mucopolysaccharidosis Therapeutics - Phase II Pipeline
5.4 Mucopolysaccharidosis Therapeutics Market - Clinical Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=1595...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.